Research & KnowledgeEvent: September 8, 2026
Voitheia BioScience Ltd is building a validated remyelination/neural repair platform as an adjunctive therapeutic class alongside existing disease-modifying treatment
Published
Signal category
Research & Knowledge
Quote
“That is the outcome worth building for Voitheia BioScience Ltd”
— Helen McCormack|Voitheia BioScience Ltd team
Company
Voitheia BioScience Ltd
VB is a clinical-stage biopharmaceutical company on a mission to address the unmet need for new and innovative medicine
- Industry
- Hospitals and Health Care
- Company size
- 2 employees
Voitheia BioScience is a clinical stage biopharmaceutical company on a mission to address the largely unmet need for new and innovative medicines in immune mediated and neurodegenerative disease. We are an all female team, steering our way through scientific breakthroughs and market defining innovation. We're building.
Founded 2024